Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postoperative suppressive therapy for thyroid adenomas.

R S Krouse1, T McCarty, L M Weiss

  • 1Department of Surgery, City of Hope National Medical Center, Duarte, California 91010, USA.

The American Surgeon
|August 31, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival.

Oncogenesis·2025
Same author

Prognostic significance of lymph node yield in ypN0 rectal cancer.

The British journal of surgery·2016
Same author

Microsporidia-Emergent Pathogens in the Global Food Chain (Trends in Parasitology 32, 336-348; April 2, 2016).

Trends in parasitology·2016
Same author

Microsporidia - Emergent Pathogens in the Global Food Chain.

Trends in parasitology·2016
Same author

Development of dual fluorescent stage specific reporter strain of Toxoplasma gondii to follow tachyzoite and bradyzoite development in vitro and in vivo.

Microbes and infection·2015
Same author

Parasitic diseases of the heart I: Acute and chronic Chagas' disease.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same journal

Complete Response of Merkel Cell Carcinoma to Immunotherapy and Single-Fraction Radiotherapy Following Severe COVID-19 Infection: A Case Report and Review of Immune Mechanism.

The American surgeon·2026
Same journal

Perioperative Acute Myocardial Infarction in Non-Cardiac Operations: A National Analysis.

The American surgeon·2026
Same journal

Outcomes of Completion Cholecystectomy: Association With Patient Comorbidity in a National Database.

The American surgeon·2026
Same journal

Building the Conversation: Editorial Stewardship in Contemporary Surgical Publishing.

The American surgeon·2026
Same journal

Musculoskeletal Pain in Surgeons on Operating Days.

The American surgeon·2026
Same journal

Splenectomy During Cytoreductive Surgery: Marker of Surgical Burden or Independent Predictor of Morbidity?

The American surgeon·2026
See all related articles

Postoperative thyroid suppression therapy after partial thyroidectomy for follicular adenoma does not reduce new nodule development. This common treatment may not be routinely indicated, offering potential cost savings.

Area of Science:

  • Endocrinology
  • Surgical Oncology
  • Thyroidology

Background:

  • Partial thyroidectomy is frequently performed for follicular thyroid adenoma.
  • Postoperative levothyroxine suppression therapy is commonly administered to prevent recurrence or new nodule formation.
  • The clinical benefit and cost-effectiveness of this postoperative therapy remain uncertain.

Purpose of the Study:

  • To evaluate the efficacy of postoperative thyroid suppression therapy in preventing new nodule development after partial thyroidectomy for follicular thyroid adenoma.
  • To assess the impact of suppression therapy on patient costs.

Main Methods:

  • Retrospective analysis of 76 patients who underwent partial thyroidectomy for follicular thyroid adenoma between 1985 and 1998.
  • Patients were categorized based on the use of postoperative thyroid suppression therapy.

Related Experiment Videos

  • Outcomes assessed included new thyroid nodule growth and reoperation rates, with a minimum follow-up of 6 months.

    • Main Results:

    • The overall recurrence rate was 4% (3/76).
    • No significant difference in new nodule development was observed between patients treated with (61%) and without postoperative suppression therapy (P = 0.274).
    • Patients not receiving levothyroxine demonstrated significant cost savings, and no reoperations were required.

    Conclusions:

    • Postoperative thyroid suppression therapy may not be routinely indicated following partial thyroidectomy for follicular thyroid adenoma.
    • The current findings suggest that withholding suppression therapy could lead to cost reductions without compromising patient outcomes.
    • Further investigation via a prospective, randomized controlled trial is warranted to definitively establish the role of suppression therapy.